Clinical Trials Browser

Phase NA × Not yet recruiting × atezolizumab × Clear all

NCT07281664 2025-12-15

Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma

Phase NA Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular